Style | Citing Format |
---|---|
MLA | Jahromi MK, et al.. "Dietary Advanced Glycation End Products Are Associated With an Increased Risk of Non-Alcoholic Fatty Liver Disease in Iranian Adults." BMC Endocrine Disorders, vol. 23, no. 1, 2023, pp. -. |
APA | Jahromi MK, Tehrani AN, Teymoori F, Daftari G, Ahmadirad H, Saber N, Salehisahlabadi A, Farhadnejad H, Mirmiran P (2023). Dietary Advanced Glycation End Products Are Associated With an Increased Risk of Non-Alcoholic Fatty Liver Disease in Iranian Adults. BMC Endocrine Disorders, 23(1), -. |
Chicago | Jahromi MK, Tehrani AN, Teymoori F, Daftari G, Ahmadirad H, Saber N, Salehisahlabadi A, Farhadnejad H, Mirmiran P. "Dietary Advanced Glycation End Products Are Associated With an Increased Risk of Non-Alcoholic Fatty Liver Disease in Iranian Adults." BMC Endocrine Disorders 23, no. 1 (2023): -. |
Harvard | Jahromi MK et al. (2023) 'Dietary Advanced Glycation End Products Are Associated With an Increased Risk of Non-Alcoholic Fatty Liver Disease in Iranian Adults', BMC Endocrine Disorders, 23(1), pp. -. |
Vancouver | Jahromi MK, Tehrani AN, Teymoori F, Daftari G, Ahmadirad H, Saber N, et al.. Dietary Advanced Glycation End Products Are Associated With an Increased Risk of Non-Alcoholic Fatty Liver Disease in Iranian Adults. BMC Endocrine Disorders. 2023;23(1):-. |
BibTex | @article{ author = {Jahromi MK and Tehrani AN and Teymoori F and Daftari G and Ahmadirad H and Saber N and Salehisahlabadi A and Farhadnejad H and Mirmiran P}, title = {Dietary Advanced Glycation End Products Are Associated With an Increased Risk of Non-Alcoholic Fatty Liver Disease in Iranian Adults}, journal = {BMC Endocrine Disorders}, volume = {23}, number = {1}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Jahromi MK AU - Tehrani AN AU - Teymoori F AU - Daftari G AU - Ahmadirad H AU - Saber N AU - Salehisahlabadi A AU - Farhadnejad H AU - Mirmiran P TI - Dietary Advanced Glycation End Products Are Associated With an Increased Risk of Non-Alcoholic Fatty Liver Disease in Iranian Adults JO - BMC Endocrine Disorders VL - 23 IS - 1 SP - EP - PY - 2023 ER - |